India May Start Producing Russian Covid-19 Sputnik V Vaccine, Says Putin
India will join the list of nations likely to start producing Russia’s Sputnik V vaccine against Covid-19, Russian President Vladmir Putin said on Tuesday.
China is also among the countries expected to take over Sputnik V production, Putin said. The Russian president also proposed to accelerate the creation of vaccine research centers in the BRICS countries: Brazil, Russia, India, China and South Africa, the Reuters news agency reported, citing TASS.
Russia, which marked its feat in the league of nations for creating the Covid-19 vaccines, announced in August that it had registered the world’s first coronavirus vaccine, Sputnik V, named after the Soviet-era satellite. However, Russia registered the vaccine before large-scale clinical trials.
The nation had claimed that its vaccine is 92 percent effective in protecting people from Covid-19 based on the results of interim trials. The results are just the second in a late-stage human trial, quickly following data published by Pfizer Inc and BioNTech, which said their injection was also more than 90 percent effective.
While nations around the world are watching the successful vaccines, they have been hit by the coronavirus pandemic that has resulted in battered economies, unemployment across nations, and overburdened public health systems, in addition to life cycle disruption. Daily, experts have raised their doubts about the Russian vaccine trial, rating the design as sparse, making the data difficult to interpret.